戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1 ze the findings into a provisional framework that can guide future studies.
2 l patients and will allow the comparison of outcome data in future studies.
3 e with MSI < 0.50 and we would advocate full LV coverage in future studies.
4  Under-represented populations warrant greater inclusion in future studies.
5 sk factors and potentially pathogenic alleles identified in future studies.
6  treatment of patients awaiting LT which may be assessed in future studies.
7                                Ultimately, our work informs future studies about functional chaperone balance and caution
8                                                             Future studies are needed to address whether similar mechanis
9 ucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiolog
10                                                             Future studies are needed to elucidate the provenance and put
11                                                             Future studies are required to specify the implications of ou
12 ession and metastasis, these results lay the groundwork for future studies assessing the therapeutic potential of targeti
13                                                             Future studies can explore the identity of these genetic fact
14 rmined 1,200 mg to be the recommended single-agent dose for future studies in FL and DLBCL, with 800 mg being sufficient
15  specific upregulated genes, which can serve as markers for future studies in healthy and diseased states.
16                                                             Future studies in patients are required to assess the potenti
17 onto other substrates makes them an attractive material for future studies in spatial heterogeneity of electrocatalytic s
18                                         Recommendations for future studies in this and similar settings include testing t
19 with a chemotherapeutic agent and provides a foundation for future studies in this difficult-to-treat patient population.
20                                                             Future studies might elucidate how brain diseases change this
21                                            We conclude that future studies need to analyze activity-driven adaptations to
22                                                             Future studies need to explore whether DNA methylation altera
23 powerful experimental strategy with broad applicability for future studies of disorders with complex genetic etiologies.
24               These data provide an invaluable resource for future studies of function and biological significance of m5C
25                                      These findings warrant future studies of intermediary metabolism in patients treated
26 distinct miRNA expression of MNs, which is likely to enrich future studies of MN disease.
27  combination, these results raise several opportunities for future studies of the pathogenesis of thyroid cancer.
28                                  These findings will inform future studies of the recently discovered RV-C, which also ap
29                                                             Future studies of these loci may aid in identifying new targe
30  develop in the HPT-JT syndrome, provide in vivo models for future studies of these tumours.
31 ceably impacts UHI intensity, which should be considered in future studies on air pollution and urban climates.
32 l for MRV in B6 mice, providing the foundation for detailed future studies on MRV with the availability of innumerable mu
33                                                             Future studies promise even more progress, with the hope that
34                                                             Future studies should assess whether therapies to ameliorate
35                                                             Future studies should attempt to replicate these results in o
36                                                             Future studies should evaluate inter-rater reliability of the
37                                                             Future studies should examine the minimum treatment intensity
38                                                             Future studies should explore risk factors for increased AL i
39                                                             Future studies should focus on better defining the role of MA
40                                                             Future studies should focus on understanding the determinants
41                                                             Future studies should measure multiple biomarkers in each can
42                                                             Future studies that focus on mechanisms, resiliency, and vuln
43 fluence to neurological disorders and point to the need for future studies to better define specific mechanisms of action
44                                    These findings encourage future studies to examine the conditions longitudinally and i
45  Together, the results of this study lay the groundwork for future studies to explore the role of DNA replication in immu
46 ng gaps in our knowledge, and make suggestions on necessary future studies to optimize organ transplantation for older pe
47                         Our results provide a framework for future studies to understand better the regulation of channel
48                        Some limitations were identified and future studies using a similar approach should aim to overcom
49  in Hispanics need to be confirmed and further explained in future studies using different measures of SEP.
50                                                             Future studies will explore methods to reduce kidney activity

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト